(GMT-05:00) Eastern Time (US & Canada)45 minutes
The panel, “Next Generation Therapeutics,” will explore the therapeutics landscape as it continues to break new ground. In Massachusetts we have had a front row seat to the extraordinary success of the mRNA COVID-19 vaccines happening in real time on the world stage. As we come off an unprecedented year and look to the future, forecasts are predicting growth from a market of $5 billion in 2020 to $58 billion in 2026, according to the Evaluate Pharma consensus. Panelists will share the latest trends they are seeing, what therapies are experiencing rapid growth, who are the therapeutic leaders, and how the landscape will evolve over the next 12 months and the market respond.
The panel, “Next Generation Therapeutics,” will explore the therapeutics landscape as it continues to break new ground. In Massachusetts we have had a front row seat to the extraordinary success of the mRNA COVID-19 vaccines happening in real time on the world stage. As we come off an unprecedented year and look to the future, forecasts are predicting growth from a market of $5 billion in 2020 to $58 billion in 2026, according to the Evaluate Pharma consensus. Panelists will share the latest trends they are seeing, what therapies are experiencing rapid growth, who are the therapeutic leaders, and how the landscape will evolve over the next 12 months and the market respond.
